TAG: China listed company

In 2024, LABUBU became a global sensation, driving revenue from The Monsters series to surge by 726.6% year-on-year and surpass RMB 3 billion [approximately USD 414.5 million], making it the group’s largest IP.

5月 12, 2025

In 2024, Youngor exited the real estate sector it had operated in for over 30 years and committed fully to the development of the fashion industry.

5月 06, 2025

On April 22, Pop Mart’s closing price reached a record high, bringing its total market capitalization to HKD 236.2 billion (approximately USD 30.2 billion).

4月 28, 2025

In 2024, Li-Ning increased its research and product development expenditure to RMB 676 million [approx. USD 93.5 million], raising its share of total revenue from 2.2% to 2.4%.

4月 03, 2025

Pop Mart expects its full-year performance in 2025 to surpass RMB 20 billion [USD 2.77 billion], with overseas revenue exceeding RMB 10 billion [USD 1.38 billion].

3月 28, 2025

The company and the Woolrich Group have completed the transfer of the related intellectual property rights.

3月 27, 2025

As a pioneer of collegiate style and a key player in British youth culture, KENT & CURWEN’s unique heritage gives it a distinctive style advantage.

3月 01, 2025

Currently, X-BIONIC is in the early stages of brand development, with mature single-brand stores achieving monthly sales of RMB 800,000 to RMB 1,000,000 (approximately USD 111,111–138,889).

1月 09, 2025

“BIEM.L.FDLKK Group will not transform KENT & CURWEN into a localized Chinese brand.”

12月 31, 2024

Bloomage Biotechnology’s stock price rose by 5.49% to 126.8 yuan per share as of February 28th, with a market value of approximately 61 billion yuan.

3月 01, 2023